{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:30Z","timestamp":1786996770546,"version":"build-2736575974"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semcancer.2020.01.009","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T11:39:35Z","timestamp":1579779575000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Tumor hypermetabolism confers resistance to immunotherapy"],"prefix":"10.1016","volume":"65","author":[{"given":"Arthur","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2020.01.009_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (80-.)"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0015","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-\u03b2: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0035","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0045","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0055","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science (80-.)"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0075","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science (80-.)"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0080","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0090","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.4049\/jimmunol.1500046","article-title":"Naive T cell maintenance and function in human aging","volume":"194","author":"Goronzy","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nature22352","article-title":"Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells","volume":"546","author":"Mendoza","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nri1710","article-title":"Fuel feeds function: energy metabolism and the T-cell response","volume":"5","author":"Fox","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0105","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2007-06-096297","article-title":"IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival","volume":"111","author":"Wofford","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon t lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ni.3598","article-title":"A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses","volume":"18","author":"Heinzel","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0125","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during t lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses InVivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"L-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0145","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0155","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.cmet.2017.05.007","article-title":"Cytochrome c oxidase activity is a metabolic checkpoint that regulates cell fate decisions during T cell activation and differentiation","volume":"25","author":"Tarasenko","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0160","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2017.02.010","article-title":"Integrative proteomics and phosphoproteomics profiling reveals dynamic signaling networks and bioenergetics pathways underlying T cell activation","volume":"46","author":"Tan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cell.2017.08.018","article-title":"Mitochondrial priming by CD28","volume":"171","author":"Klein Geltink","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0175","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.celrep.2012.10.009","article-title":"T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation","volume":"2","author":"Kami\u0144ski","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0180","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1128\/MCB.02295-06","article-title":"Novel role for mitochondria: protein kinase C -dependent oxidative signaling organelles in activation-induced T-cell death","volume":"27","author":"Kaminski","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2016.06.007","article-title":"Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation","volume":"24","author":"Ron-Harel","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8 + T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","article-title":"Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development","volume":"41","author":"O\u2019Sullivan","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature21379","article-title":"Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism","volume":"543","author":"Pan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0210","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1073\/pnas.1221740110","article-title":"CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability","volume":"110","author":"Van Der Windt","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0215","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2687","article-title":"Rapid effector function of memory CD8 + T cells requires an immediate-early glycolytic switch","volume":"14","author":"Gubser","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0220","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (review)","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0225","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science (80-.)"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0230","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.1058079","article-title":"Cooperation and competition in the evolution of ATP-Producing pathways","volume":"292","author":"Pfeiffer","year":"2001","journal-title":"Science (80-.)"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0245","first-page":"780","article-title":"The interstitial fluid of solid tumors","volume":"24","author":"Gullino","year":"1964","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0250","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.4049\/jimmunol.174.8.4670","article-title":"Glucose availability regulates IFN-\u03b3 production and p70S6 kinase activation in CD8 + effector T cells","volume":"174","author":"Cham","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0255","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.immuni.2006.03.018","article-title":"The Noxa\/Mcl-1 Axis Regulates susceptibility to apoptosis under glucose limitation in dividing T cells","volume":"24","author":"Alves","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0260","first-page":"710","volume":"146","author":"Group","year":"1977"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0265","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/eji.200838289","article-title":"Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells","volume":"38","author":"Cham","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0270","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.1502464","article-title":"Suppression of Glut1 and glucose metabolism by decreased Akt\/mTORC1 signaling drives T cell impairment in B cell leukemia","volume":"197","author":"Siska","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0275","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aap9520","article-title":"Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells","volume":"4","author":"Gemta","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0280","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ni.3313","article-title":"Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction","volume":"17","author":"Zhao","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0290","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.celrep.2019.04.022","article-title":"Acetate promotes T cell effector function during glucose restriction","volume":"27","author":"Qiu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0295","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0300","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0305","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased tumor glycolysis characterizes immune resistance to adoptive t cell therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0310","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0315","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0320","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ijc.26410","article-title":"Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation","volume":"131","author":"Mendler","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate regulates metabolic and proinflammatory circuits in control of T cell migration and effector functions","volume":"13","author":"Haas","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0330","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.4049\/jimmunol.147.10.3638","article-title":"Comparative studies of the cytotoxic T lymphocyte-mediated cytotoxicity and of extracellular ATP-induced cell lysis: different requirements in extracellular Mg2+ and pH","volume":"147","author":"Redegeld","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0335","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.imlet.2015.07.003","article-title":"Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes","volume":"167","author":"Nakagawa","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0340","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0345","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of tumor acidity improves antitumor responses to immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0350","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","article-title":"Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically","volume":"7","author":"Chafe","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0355","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0365","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0375","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: Significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0380","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1158\/0008-5472.CAN-14-2598","article-title":"Mechanisms of hypoxia-mediated immune escape in cancer","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0385","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/onc.2016.225","article-title":"Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer","volume":"36","author":"Chouaib","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0390","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.4049\/jimmunol.174.12.7592","article-title":"TCR engagement increases hypoxia-inducible Factor-1\u03b1 protein synthesis via Rapamycin-Sensitive pathway under hypoxic conditions in human peripheral T cells","volume":"174","author":"Nakamura","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0395","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ni.2714","article-title":"Hypoxia-inducible factors enhance the effector responses of CD8 + T cells to persistent antigen","volume":"14","author":"Doedens","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0400","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","article-title":"Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche","volume":"166","author":"Clever","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0405","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.4049\/jimmunol.167.11.6140","article-title":"Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions","volume":"167","author":"Caldwell","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0410","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.celrep.2017.08.071","article-title":"Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function","volume":"20","author":"Gropper","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1165\/rcmb.2008-0139OC","article-title":"T-cell activation under hypoxic conditions enhances IFN-\u03b3 secretion","volume":"42","author":"Roman","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0420","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.mt.6300391","article-title":"Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment","volume":"16","author":"Kim","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0425","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1073\/pnas.0409910102","article-title":"Culturing at atmospheric oxygen levels impacts lymphocyte function","volume":"102","author":"Atkuri","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11050602","article-title":"Hypoxia selectively impairs CAR-T cells in vitro","volume":"11","author":"Berahovich","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0435","doi-asserted-by":"crossref","first-page":"A251","DOI":"10.1097\/00000542-199209001-00251","article-title":"The effects of hypoxia on interleukin-2 (IL2) mRNA expression","volume":"77","author":"Zuckerberg","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0440","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1073\/pnas.0506070102","article-title":"Hypoxia inducible factor 1\u03b1 regulates T cell receptor signal transduction","volume":"102","author":"Neumann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0445","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000189191","article-title":"Enhanced interferon-\u03b3 gene expression in T cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-\u03b1- deficient mice","volume":"149","author":"Guo","year":"2009","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0450","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.4049\/jimmunol.177.8.4962","article-title":"Cutting edge: hypoxia-inducible factor 1\u03b1 and its activation-inducible short isoform I.1 negatively regulate functions of CD4 + and CD8 + t lymphocytes","volume":"177","author":"Lukashev","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0455","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0543-y","article-title":"Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors","volume":"7","author":"Rytelewski","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0475","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00262-019-02361-5","article-title":"Reduced CTL motility and activity in avascular tumor areas","volume":"68","author":"Manaster","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0480","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1\u03b1-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0485","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1074\/jbc.M010144200","article-title":"Regulation of glut1 mRNA by hypoxia-inducible factor-1: interaction between H-ras and hypoxia","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0490","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0495","first-page":"7992","article-title":"Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer","volume":"61","author":"Giatromanolaki","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0500","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0505","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0510","first-page":"1282","article-title":"Foxp3 reprograms T cell metabolism to function in article Foxp3 reprograms t cell metabolism to function in low-glucose","author":"Environments","year":"2017","journal-title":"High-Lactate Environ."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0515","first-page":"2602","article-title":"The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine","volume":"57","author":"Blay","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0520","first-page":"993","article-title":"By hypoxia-inducible Factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"October"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0525","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0530","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2009.03075.x","article-title":"Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling","volume":"128","author":"Linnemann","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0535","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V90.4.1600","article-title":"Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0540","first-page":"1","volume":"5","author":"Cd","year":"2019"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0545","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/0008-5472.CAN-09-3109","article-title":"CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0550","first-page":"527","article-title":"Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)","volume":"32","author":"Hoskin","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0555","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1182\/blood-2007-11-126763","article-title":"HIF-l-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak","volume":"111","author":"Morote-Garcia","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0560","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","article-title":"T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 t cells by converting 5\u2032-Adenosine monophosphate to adenosine","volume":"177","author":"Kobie","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0565","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0570","volume":"2","author":"Gr\u00e9nman","year":"2016"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0575","series-title":"Site-specific Activation of AKT Protects Cells From Death Induced by Glucose Deprivation","first-page":"745","author":"Gao","year":"2014"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0580","first-page":"1","volume":"8","author":"Marijt","year":"2019"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0585","series-title":"Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression","first-page":"2395","author":"Chandrasekaran","year":"2019"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0590","first-page":"3264","volume":"129","author":"Sivaram","year":"2019"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0595","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00109-014-1189-3","article-title":"Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1\u03b1-dependent and extracellular adenosine-mediated tumor protection","volume":"92","author":"Hatfield","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0600","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0605","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0610","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1021\/jm701028q","article-title":"Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs","volume":"51","author":"Duan","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0615","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122204","article-title":"Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma","volume":"3","author":"Jamieson","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0620","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"Lebleu","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0625","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines4040046","article-title":"Tumor microenvironment metabolism: a new checkpoint for anti-tumor immunity","volume":"4","author":"Scharping","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0635","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93411","article-title":"Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma","volume":"2","author":"Siska","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0640","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","article-title":"Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0645","first-page":"1","article-title":"Oncolytic viruses engineered to enforce leptin expression, reprogram tumor-infiltrating T cell metabolism, and promote tumor clearance","author":"Rivadeneira","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0650","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0655","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/2326-6066.CIR-17-0767","article-title":"Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation","volume":"6","author":"Teijeira","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0660","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0665","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"1021","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0670","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124989","article-title":"Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma","volume":"4","author":"Najjar","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcancer.2020.01.009_bib0675","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/2159-8290.CD-18-1489","article-title":"Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases","volume":"9","author":"Fischer","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2020.01.009_bib0680","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","article-title":"Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence","volume":"179","author":"Harel","year":"2019","journal-title":"Cell"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20300092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20300092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:36:58Z","timestamp":1760917018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X20300092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":136,"alternative-id":["S1044579X20300092"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.01.009","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor hypermetabolism confers resistance to immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}